TL;DR CNBC

2024-05-23 12:46:58

This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A

POSITIVE
BMY, LLY, NOV.N-CH, AZN-GB, FUSN, NVS,